- Category
- Micro (2022-23)
- Udyam number
- UDYAM-PB-20-0028952

Amicable Pharmaceuticals Private Limited
About Amicable Pharmaceuticals Private Limited
Data last updated:
Amicable Pharmaceuticals Private Limited is a private limited company based in Zirakpur, Punjab, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 29 March 2022.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51909PB2022PTC055523.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nitin Goyal and Deepak Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 2 Trishla Society Road Peermuchalla, Zirakpur, Punjab, India – 140603.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.59 Cr, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹4.64 Lakh (net margin 2.9%) and EBITDA of ₹9.23 Lakh (EBITDA margin 5.8%).
As per MCA filings, the company has open charges of ₹15.09 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company; 2 cases are pending.
Amicable Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-20-0028952).
Company details
Recognitions & Rankings of Amicable Pharmaceuticals
Contact details
Amicable Pharmaceuticals Private Limited's registered office is in Zirakpur, Punjab.
- Registered AddressScf 2 Trishla Society Road Peermuchalla, Zirakpur, Punjab, India – 140603
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Amicable Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Amicable Pharmaceuticals Private Limited, buy the company report.
Financials of Amicable Pharmaceuticals Private Limited
FY 2025 filings availableAmicable Pharmaceuticals Private Limited reported revenue of ₹1.59 Cr (up 38% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 38% in the latest year. EBITDA rose 119% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹9.23 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹4.64 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 5.8% | |||
| Net Profit Margin | 2.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Amicable Pharmaceuticals Private Limited, buy the company report.
Board of directors of Amicable Pharmaceuticals Private Limited
Amicable Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Goyal Also directs: Tyscon Pharmaceuticals Private Limited | Director | 29 Mar 2022 | 4 Years 7 Months | Current |
| Deepak Goyal Also directs: Tyscon Pharmaceuticals Private Limited | Director | 29 Mar 2022 | 4 Years 7 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Sep 2024 | 100998809 | Hdfc Bank Limited | ₹15.09 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Amicable Pharmaceuticals Private Limited has 2 court cases on record: 2 filed by Amicable Pharmaceuticals. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, SAS Nagar, Punjab | Cheque dishonour complaint | Filed by the company against M/S Aarab Pharmaceuticals | Pending |
| District court, SAS Nagar, Punjab | Cheque dishonour complaint | Filed by the company against M/S Ram Medical Agency | Pending |
To see the full case history of Amicable Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amicable Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Amicable Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Amicable Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Deepak Goyal was appointed as Director on 29 Mar 2022.
Frequently asked questions
Amicable Pharmaceuticals is an active private limited company based in Zirakpur, Punjab, India. The company works in specialty, within the trading industry. It was incorporated on 29 March 2022 (4+ years old) and is registered under CIN U51909PB2022PTC055523.
Amicable Pharmaceuticals has 2 current directors:
- Nitin Goyal - Director
- Deepak Goyal - Director
The latest financial statements of Amicable Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Amicable Pharmaceuticals is U51909PB2022PTC055523. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amicable Pharmaceuticals has 2 court cases on record: 2 filed by the company. 2 are pending.
Amicable Pharmaceuticals was incorporated on 29 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Chandigarh.
Deepak Goyal was appointed as Director on 29 Mar 2022. Nitin Goyal was appointed as Director on 29 Mar 2022.
Yes, Amicable Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-PB-20-0028952).
The registered office of Amicable Pharmaceuticals is at Scf 2 Trishla Society Road Peermuchalla, Zirakpur, Punjab, India – 140603.
Amicable Pharmaceuticals operates in the trading industry, in the specialty segment.

